Through the @TODAYshow Expert Tip of the Day, Dr. Anum Minhas encourages people taking supplements to check in with their pharmacist and medical team first to avoid any unintended interactions: https://t.co/0vEJcj5ajO. @hopkinsheart
.@jaideeppatelmd speaks to @WHYYNews about new research initiatives to study emerging treatment options for rare conditions, like homozygous familial hypercholesterolemia, an inherited condition that affects about 1 in 300,000 people: https://t.co/mMOEClCMFW @hopkinsheart
What options for treating #Menopause exist after a person has had a #Stroke or if they have increased #CVD risks? Dr. Anum Minhas shares insight about factors people and their healthcare providers should consider: https://t.co/KpP03NDPg3 @HopkinsHeart#PreventiveCardiology
"@AaronTroyMD , a cardiovascular medicine fellow at Johns Hopkins and director of the Johns Hopkins Healthy Heart Aging Program, says the bigger question is how coffee fits in with a person’s health and daily routine." ☕️ More on caffeine & heart health:
https://t.co/QOtqekbmFO
Congratulations to @CiccaroneCenter & @HopkinsHeart super⭐️ + NBA insider Dr. Aaron Troy on the first day of his Healthy Heart Aging Program at Green Spring. In honor of the recent #Knicksin5!, we have adopted @Knicks 🧢’s with ‘70, ‘73, & ‘26 as the official headgear.
Johns Hopkins Medicine is one of 15 centers that will be part of a pivotal @American_Heart research network to study and transform care for people receiving heart transplants: https://t.co/dwxNz6DEXY. #PrecisionMedicine#HeartTransplant
To develop more personalized and effective therapies, this harmonized research network will study early features of heart transplant rejection, provide remote monitoring, and include viral surveillance to study infection-related risks.
Impella, the world’s smallest heart pump, has been shown to improve survival in patients who have suffered a severe #HeartAttack and acute #HeartFailure, and was recently introduced by @HwangChao into Frederick Health’s catheterization laboratory: https://t.co/M08LaNWXyO.
“Heart, kidney and metabolic conditions don’t occur in isolation — they are deeply connected,” says Dr. Chiadi Ndumele, chair of the guideline-writing committee for the 2026 ACC Cardiovascular-Kidney-Metabolic Syndrome Guideline: https://t.co/U1iHNTvLI8 @CiccaroneCenter
Truly privileged to be working with an amazing #StructuralTeam@hopkinsheart@HopkinsMedicine On May 13th, the team shared accomplishments, new or innovative updates, clinical trial updates, lessons and the program's future direction. @RaniKHasan
The new guideline for blood cholesterol and lipid management focuses on personalizing #ASCVD risk assessments. Read a case study about a woman with a family history of #CHD who received personalized insight to take steps to further offset risks: https://t.co/ytP1ybImYG.
@rblument1@SethShayMartin Sports fans can break down a pick-and-roll or recite championship stats. Cardiologists can recite LDL targets & landmark trials. @rblument1 combines both, bringing the passion of a true sports fan together w/ the rigor & humanity that define the very best of preventive cardiology
Congratulations to our Humanism in Cardiology Award recipient, Milan Kaushik, MD! This honor recognizes a fellow who exemplifies compassionate patient care, generosity, professionalism, and respect toward colleagues, while serving as an outstanding role model among peers.
Recent research has shown that, while nonstatin prescription rates are climbing in ASCVD, statin therapies still outpace them by several orders of magnitude. Michael Blaha, MD, MPH, from Johns Hopkins, joins HCPLive to explain how to change this trend.
https://t.co/FX9QGshhGZ
Congratulations to Allison Peng, recipient of this year's Silverman Award! @AllisonWPeng Her research on INOCA phenotypes in women aims to improve risk prediction and personalize treatment. A well-deserved honor recognizing originality and creativity! 🏆👏